资讯内容 Content
[ESH2010]高血压合并心衰患者房颤治疗进展——M. Schneider教授专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。
< International Circulation>: Compared with other atrial fibrillation therapy, what is the advantage of the RAS inhibitor?
Prof. Schneider: The main advantage is that they have very low side-effects. We know that treating patients that have atrial fibrillation can be very difficult. All the anti-arrhythmic drugs that we have have a substantial amount of side-effects. Additionally there are surgical procedures that are not free of side-effects. By using an ACE inhibitor and an ARB which has a very good side-effect profile, that is one of the advantages. Also, these drugs might actually work on the substrate for atrial fibrillation whereas anti-arrhythmic drugs are also very important, the RAS blockade drugs are also very useful because they work on the substrate or cause of atrial fibrillation.
上一页 [1] [2] [3] [4] 下一页